Our data supported the idea that Cyy-287 could effectively protect against obesity-induced cardiac and hepatic damage by inhibiting the NF-κB mediated inflammatory pathway. The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.